Integral Ad Science (NASDAQ:IAS) Releases Earnings Results, Misses Estimates By $0.03 EPS

Integral Ad Science (NASDAQ:IASGet Free Report) announced its quarterly earnings results on Friday. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.03), Zacks reports. The business had revenue of $153.00 million for the quarter, compared to the consensus estimate of $148.83 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business’s revenue for the quarter was up 13.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.06 EPS. Integral Ad Science updated its FY 2025 guidance to EPS and its Q1 2025 guidance to EPS.

Integral Ad Science Trading Up 8.5 %

Shares of Integral Ad Science stock traded up $0.83 on Friday, hitting $10.48. The stock had a trading volume of 1,899,731 shares, compared to its average volume of 860,241. The stock’s 50-day simple moving average is $10.33 and its two-hundred day simple moving average is $10.82. Integral Ad Science has a one year low of $7.98 and a one year high of $13.62. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. The stock has a market cap of $1.70 billion, a price-to-earnings ratio of 52.43, a PEG ratio of 1.06 and a beta of 1.46.

Analysts Set New Price Targets

A number of equities analysts have issued reports on IAS shares. Oppenheimer reiterated an “outperform” rating on shares of Integral Ad Science in a research note on Friday. Truist Financial dropped their target price on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Piper Sandler reduced their target price on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating for the company in a report on Wednesday, November 13th. Craig Hallum decreased their price target on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Finally, Benchmark restated a “hold” rating on shares of Integral Ad Science in a research note on Friday. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $14.80.

View Our Latest Research Report on IAS

Insider Buying and Selling at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 12,448 shares of the firm’s stock in a transaction on Tuesday, February 4th. The stock was sold at an average price of $10.61, for a total transaction of $132,073.28. Following the completion of the transaction, the chief executive officer now owns 278,650 shares of the company’s stock, valued at approximately $2,956,476.50. This trade represents a 4.28 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Over the last quarter, insiders have sold 19,109 shares of company stock worth $197,696. 2.00% of the stock is currently owned by company insiders.

Integral Ad Science Company Profile

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Recommended Stories

Earnings History for Integral Ad Science (NASDAQ:IAS)

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.